Literature DB >> 33446449

How Comorbidities Shape Cancer Biology and Survival.

Gatikrushna Panigrahi1, Stefan Ambs2.   

Abstract

Comorbid chronic diseases affect cancer patients with an increasing frequency as populations get older. They negatively and disproportionately impact underserved populations and influence cancer diagnosis, tumor biology and metastasis, and choice of treatment. Many comorbidities are associated with a delayed cancer diagnosis. Although the relationship between comorbidities and cancer risk and survivorship has been studied extensively, we still lack knowledge on how they affect tumor biology and the metastatic process. Here, we will discuss our current understanding of mechanisms linking comorbidities to an adverse tumor biology and lethality and introduce thoughts of how we can close existing gaps in this knowledge. We argue that research into comorbidity-induced alterations in cancer metastasis, immunity, and metabolism should be prioritized. Published by Elsevier Inc.

Entities:  

Keywords:  cancer; comorbidity; diabetes; health disparity; immunity; metabolism; metastasis; obesity; survival

Mesh:

Year:  2021        PMID: 33446449      PMCID: PMC8137526          DOI: 10.1016/j.trecan.2020.12.010

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  65 in total

1.  Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Authors:  Joseph M Unger; Dawn L Hershman; Mark E Fleury; Riha Vaidya
Journal:  JAMA Oncol       Date:  2019-03-01       Impact factor: 31.777

2.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.

Authors:  Shin Yoshimoto; Tze Mun Loo; Koji Atarashi; Hiroaki Kanda; Seidai Sato; Seiichi Oyadomari; Yoichiro Iwakura; Kenshiro Oshima; Hidetoshi Morita; Masahira Hattori; Masahisa Hattori; Kenya Honda; Yuichi Ishikawa; Eiji Hara; Naoko Ohtani
Journal:  Nature       Date:  2013-06-26       Impact factor: 49.962

Review 3.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.

Authors:  Konstantinos K Tsilidis; John C Kasimis; David S Lopez; Evangelia E Ntzani; John P A Ioannidis
Journal:  BMJ       Date:  2015-01-02

4.  High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity.

Authors:  Manon D Schulz; Ciğdem Atay; Jessica Heringer; Franziska K Romrig; Sarah Schwitalla; Begüm Aydin; Paul K Ziegler; Julia Varga; Wolfgang Reindl; Claudia Pommerenke; Gabriela Salinas-Riester; Andreas Böck; Carl Alpert; Michael Blaut; Sara C Polson; Lydia Brandl; Thomas Kirchner; Florian R Greten; Shawn W Polson; Melek C Arkan
Journal:  Nature       Date:  2014-08-31       Impact factor: 49.962

Review 5.  Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Authors:  Adi J Klil-Drori; Laurent Azoulay; Michael N Pollak
Journal:  Nat Rev Clin Oncol       Date:  2016-08-09       Impact factor: 66.675

6.  Heart Failure Stimulates Tumor Growth by Circulating Factors.

Authors:  Wouter C Meijers; Manuel Maglione; Stephan J L Bakker; Rupert Oberhuber; Lyanne M Kieneker; Steven de Jong; Bernhard J Haubner; Wouter B Nagengast; Alexander R Lyon; Bert van der Vegt; Dirk J van Veldhuisen; B Daan Westenbrink; Peter van der Meer; Herman H W Silljé; Rudolf A de Boer
Journal:  Circulation       Date:  2018-08-14       Impact factor: 29.690

7.  Level of disability, multi-morbidity and breast cancer screening: does severity matter?

Authors:  Sara J T Guilcher; Aisha Lofters; Richard H Glazier; Susan B Jaglal; Jennifer Voth; Ahmed M Bayoumi
Journal:  Prev Med       Date:  2014-07-27       Impact factor: 4.018

8.  Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.

Authors:  Caroline P Le; Cameron J Nowell; Corina Kim-Fuchs; Edoardo Botteri; Jonathan G Hiller; Hilmy Ismail; Matthew A Pimentel; Ming G Chai; Tara Karnezis; Nicole Rotmensz; Giuseppe Renne; Sara Gandini; Colin W Pouton; Davide Ferrari; Andreas Möller; Steven A Stacker; Erica K Sloan
Journal:  Nat Commun       Date:  2016-03-01       Impact factor: 14.919

9.  Obesity-associated NLRC4 inflammasome activation drives breast cancer progression.

Authors:  Ryan Kolb; Liem Phan; Nicholas Borcherding; Yinghong Liu; Fang Yuan; Ann M Janowski; Qing Xie; Kathleen R Markan; Wei Li; Matthew J Potthoff; Enrique Fuentes-Mattei; Lesley G Ellies; C Michael Knudson; Mong-Hong Lee; Sai-Ching J Yeung; Suzanne L Cassel; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Nat Commun       Date:  2016-10-06       Impact factor: 14.919

10.  Critical role for arginase 2 in obesity-associated pancreatic cancer.

Authors:  Tamara Zaytouni; Pei-Yun Tsai; Daniel S Hitchcock; Cory D DuBois; Elizaveta Freinkman; Lin Lin; Vicente Morales-Oyarvide; Patrick J Lenehan; Brian M Wolpin; Mari Mino-Kenudson; Eduardo M Torres; Nicholas Stylopoulos; Clary B Clish; Nada Y Kalaany
Journal:  Nat Commun       Date:  2017-08-14       Impact factor: 14.919

View more
  3 in total

Review 1.  Twenty Important Research Questions in Microbial Exposure and Social Equity.

Authors:  Jake M Robinson; Nicole Redvers; Araceli Camargo; Christina A Bosch; Martin F Breed; Lisa A Brenner; Megan A Carney; Ashvini Chauhan; Mauna Dasari; Leslie G Dietz; Michael Friedman; Laura Grieneisen; Andrew J Hoisington; Patrick F Horve; Ally Hunter; Sierra Jech; Anna Jorgensen; Christopher A Lowry; Ioana Man; Gwynne Mhuireach; Edauri Navarro-Pérez; Euan G Ritchie; Justin D Stewart; Harry Watkins; Philip Weinstein; Suzanne L Ishaq
Journal:  mSystems       Date:  2022-01-04       Impact factor: 6.496

2.  Therapeutic Perspectives for the Perioperative Period in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Antoine Galmiche; Zuzana Saidak; Jérémie Bettoni; Martial Ouendo; Sylvie Testelin
Journal:  Front Oral Health       Date:  2022-01-11

3.  Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain.

Authors:  Francisco Javier Rubio; Danilo Alvares; Daniel Redondo-Sanchez; Rafael Marcos-Gragera; María-José Sánchez; Miguel Angel Luque-Fernandez
Journal:  BMC Med Res Methodol       Date:  2022-04-03       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.